USC study tests if mindfulness boosts psilocybin's antidepressant effects
USC study tests if mindfulness boosts psilocybin's antidepressant effects
USC study tests if mindfulness boosts psilocybin's antidepressant effects
A new clinical study at the University of Southern California is exploring psychedelic therapy using psilocybin. The research aims to assess whether mindfulness meditation can boost the treatment’s benefits for depression. The FDA has already recognised psilocybin as a breakthrough therapy for major depressive disorder and treatment-resistant cases. The investigation involves around 72 middle-aged adults from the Los Angeles area. Participants are split into two groups: one receiving psilocybin alone, the other combining it with mindfulness meditation training. Dr Rael Cahn and Dr Caryn Lerman, specialists in mindfulness science and psychiatry, are co-leading the project.
Before and after the intervention, researchers will conduct extensive assessments. These include EEG, MRI/fMRI scans, biological sampling, and psychological tests. The study uses an open-label design, ensuring full transparency, and employs advanced neuroimaging and biological assays.
Follow-up evaluations at three, six, and twelve months will track the lasting effects of the treatment. Psilocybin is known to alter sensory processing, time perception, and self-awareness, often leading to deep spiritual experiences. The research is funded by a grant from ARPA-H under its EVIDENT initiative. The study seeks to determine if mindfulness can enhance psilocybin’s therapeutic impact. Results could provide new insights into rapid-acting treatments for depression. The findings will be closely monitored over the coming year.
California judge blocks attempt to expose UCLA's pro-Palestinian event speakers
Free speech wins as a judge halts a campaign to silence Palestinian rights advocates. The decision exposes the dangers of lawfare targeting campus activism.
Vitl's personalised supplements hit Sainsbury's shelves nationwide
From immunity boosts to sleep support, Vitl's science-driven vitamins are now just an aisle away. Could this be the future of personalised wellness?
German nursing care reform faces delay as industry leader demands major revisions
A bold call to halt the reform shakes Berlin. With €1.8 billion at stake and welfare risks looming, will the government rewrite—or rush—ahead?
Stanford's BurgerAI Crafts the Perfect Burger—And It Beats a Big Mac
What if the juiciest, healthiest burger you ever ate was designed by an algorithm? Stanford's AI just proved it's possible—and it's changing fast food forever.